Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
Public ClinicalTrials.gov record NCT01940276. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Open-label, Parallel Group Study of Abiraterone Acetate Plus Prednisone in African American and Caucasian Men With Metastatic Castrate-resistant Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary goal is to prospectively estimate the median radiographic PFS of African American and Caucasian men with mCRPC to abiraterone acetate and prednisone.
Study identification
- NCT ID
- NCT01940276
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2013 (Actual)
- Primary completion
- Oct 8, 2019 (Actual)
- Completion
- Oct 8, 2019 (Actual)
- Last update posted
- Dec 9, 2020
2013 – 2019
United States locations
- U.S. sites
- 14
- U.S. states
- 6
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham VA Medical Center | Birmingham | Alabama | 35233 | — |
| Tulane Cancer Center | New Orleans | Louisiana | 70112 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Maria Parham Medical Center | Henderson | North Carolina | 27536 | — |
| Scotland Memorial Hospital | Laurinburg | North Carolina | 28352 | — |
| Southeastern Regional | Lumberton | North Carolina | 28359 | — |
| Duke Raleigh Hospital | Raleigh | North Carolina | 27609 | — |
| W. G. 'Bill' Hefner VA Medical Center | Salisbury | North Carolina | 28144 | — |
| Johnston Memorial Hospital | Smithfield | North Carolina | 27577 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| Spartanburg Regional | Spartanburg | South Carolina | 29303 | — |
| Virginia Oncology Associates | Hampton | Virginia | 23666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01940276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01940276 live on ClinicalTrials.gov.